Published eLetters
If you would like to comment on this article, click on Submit a Response to This article, below. We welcome your input.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Evaluation of a Program Designed to Support Implementation of Prescribing Medication for Treatment of Opioid Use Disorder in Primary Care Practices
- Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan
- Increasing North Carolinas Workforce Capacity for Prescribing Buprenorphine Products
- Increasing Capacity for Treatment of Opioid Use Disorder in Rural Primary Care Practices
- The Next Step in Expanding Treatment of Opioid Use Disorder?
- Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care
- Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model
- The Impact on Future Prescribing Patterns of Opioid Use Disorder (OUD) Education and Waiver Provision During Residency
- The Value of Treating Opioid Use Disorder in Family Medicine: From the Patient Perspective
- A Financial Model for Team-Based Opioid Use Disorder Treatment
- Practice Predictors of Buprenorphine Prescribing by Family Physicians
- Supporting Physicians and Practice Teams in Efforts to Address the Opioid Epidemic
- Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States
- Stabilizing the Mother-Infant Dyad for Better Outcomes from OB to FM: Caring for Patients with Perinatal Opioid Use Disorder through the 4th Trimester
- Now is the Time to Address Substance Use Disorders in Primary Care
- In This Issue: Trends, Prescribing, Deprescribing